Novavax
NVAX
#5814
Rank
NZ$1.88 B
Marketcap
NZ$11.63
Share price
-1.31%
Change (1 day)
-23.99%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2025 (TTM): NZ$3.70

According to Novavax's latest financial reports the company's current EPS (TTM) is NZ$3.63. In 2024 the company made an earnings per share (EPS) of NZ-$2.10.

EPS history for Novavax from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.70-275.92%
2024NZ-$2.10
2022NZ-$14.20-64.36%
2021NZ-$39.83243%
2020NZ-$11.6119.75%
2019NZ-$9.70-43.86%
2018NZ-$17.27-19.84%
2017NZ-$21.55-38.83%
2016NZ-$35.2374.58%
2015NZ-$20.1863.89%
2014NZ-$12.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Agenus
AGEN
NZ-$5.32-246.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.69-229.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.41-33.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08551-102.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.19 43.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$2.94-18.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.59 247.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
NZ-$1.04-128.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.15 69.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ-$5.78-259.43%๐Ÿ‡บ๐Ÿ‡ธ USA